Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia

Clinical trial NCT07202143 · RECRUITING

Trial details

NCT number: NCT07202143
Sponsor: YiLin
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Large Infarct Core Post-stroke Lymphocytopenia

Start date: 2025-09-01
Primary completion: 2026-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.